This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

David Entwistle, Ph.D.
Head of Process Chemistry at Codexis
Speaker

Profile

David Entwistle is the Head of Process Chemistry at Codexis, leading the company’s research efforts in sustainable chemistry programs for both small molecule therapeutics manufacturing and enzymatic oligonucleotide synthesis. Prior to joining Codexis in 2012, he was a synthetic organic chemist for Pfizer Process Chemistry in the UK for over a decade, working on many early- to mid-clinical phase APIs. David obtained his Ph.D. from Imperial College London in 1994 under Prof. Steve Ley FRS. His postdoctoral positions with Prof. Tomas Hudlicky and Prof. Gerry Pattenden FRS focused on synthetic organic methodologies and total synthesis.

Agenda Sessions

  • Revolutionizing Nucleic Acid Synthesis with Engineered Enzymes

    13:25